Suowen Xu
University of Science and Technology of China
H-index: 62
Asia-China
Top articles of Suowen Xu
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
NAFLD and NASH: etiology, targets and emerging therapies | Shulin Wei Li Wang Paul C Evans Suowen Xu | 2024/2/1 | |
Epigenetic Regulation in Cardiovascular Diseases, Volume III | Suowen Xu Indulekha CL Pillai Christoph D Rau Zhihua Wang | 2023/3/6 | |
SIRT6 protects against lipopolysaccharide-induced inflammation in human pulmonary lung microvascular endothelial cells | Inflammation | Jinping Wang Jinque Luo Dante Rotili Antonello Mai Clemens Steegborn | 2024/2 |
Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway | Acta Pharmacologica Sinica | Xia-yun Ni Xiao-jun Feng Zhi-hua Wang Yang Zhang Peter J Little | 2024/4/8 |
TRIM56 protects against non-alcoholic fatty liver disease via promoting the degradation of fatty acid synthase | The Journal of Clinical Investigation | Suowen Xu Xiumei Wu Sichen Wang Mengyun Xu Tingyu Fang | 2024/1/11 |
Kaempferol and atherosclerosis: From mechanism to medicine | Meijie Chen Jianbo Xiao Hesham R El-Seedi Krystyna Skalicka Woźniak Maria Daglia | 2024/3/22 | |
A proteome-wide screen identifies the calcium binding proteins, S100A8/S100A9, as clinically relevant therapeutic targets in aortic dissection | Pharmacological Research | Hui Jiang Yaping Zhao Meiming Su Lu Sun Meijie Chen | 2024/1/1 |
A novel mouse model of familial combined hyperlipidemia and atherosclerosis | Acta Pharmacologica Sinica | Mei-jie Chen Yi-tong Xu Lu Sun Zhi-hua Wang Peter J Little | 2024/3/8 |
Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery | Si Gao Xue-ping Liu Ting-ting Li Li Chen Yi-ping Feng | 2024/1 | |
Moscatilin inhibits vascular calcification by activating IL13RA2-dependent inhibition of STAT3 and attenuating the WNT3/β-catenin signalling pathway | Journal of Advanced Research | Tingting Zhang Mengmeng Zhu Jialing Ma Zhenghong Liu Zhidan Zhang | 2024/3/2 |
Blockade of endothelial adenosine receptor 2 A suppresses atherosclerosis in vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition | Pharmacological Research | Yongfeng Cai Yaqi Zhou Qiuhua Yang Jiean Xu Qingen Da | 2024/5/1 |
Growth differentiation factor 15 is dispensable for acetaminophen‐induced liver injury in mice | Basic & Clinical Pharmacology & Toxicology | Peng Jiang Zhenghong Liu Tingyu Fang Zhidan Zhang Yu Zhang | 2023/4 |
AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation | Antioxidants | Lijing Kang Juanjuan Yi Chi-Wai Lau Lei He Qinghua Chen | 2023/8/28 |
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies | Xiumei Wu Mengyun Xu Mengya Geng Shuo Chen Peter J Little | 2023/5/27 | |
Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics | Shofiul Azam Md Jakaria In-Su Kim Joonsoo Kim Md Ezazul Haque | 2019/5/10 | |
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies | Suo-wen Xu Iqra Ilyas Jian-ping Weng | 2023/4 | |
Transcription factor 21 accelerates vascular calcification in mice by activating the IL-6/STAT3 signaling pathway and the interplay between VSMCs and ECs | Acta Pharmacologica Sinica | Xiao-kang Zhao Meng-meng Zhu Sheng-nan Wang Ting-ting Zhang Xiao-ning Wei | 2023/8 |
Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 | EClinicalMedicine | Sara Momtazmanesh Sahar Saeedi Moghaddam Seyyed-Hadi Ghamari Elaheh Malakan Rad Negar Rezaei | 2023/5/1 |
Anti-atherosclerotic effects and molecular targets of ginkgolide B from Ginkgo biloba | Weile Ye Jiaojiao Wang Peter J Little Jiami Zou Zhihua Zheng | 2023/9/23 | |
ASGR1: an emerging therapeutic target in hypercholesterolemia | Signal Transduction and Targeted Therapy | Wenqi Zhao Suowen Xu Jianping Weng | 2023/1/23 |
